Personal experience of helping her son juggle sight loss and adolescence means Francesca Müeller understands all too well the importance of peer support.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh